DrugPatentWatch Database Preview

Therapeuticsmd Inc Company Profile

« Back to Dashboard

What is the competitive landscape for THERAPEUTICSMD INC, and what generic alternatives to THERAPEUTICSMD INC drugs are available?

THERAPEUTICSMD INC has three approved drugs.

There are thirteen US patents protecting THERAPEUTICSMD INC drugs.

There are eighty-seven patent family members on THERAPEUTICSMD INC drugs in twelve countries and twenty-seven supplementary protection certificates in eleven countries.

Summary for Therapeuticsmd Inc

International Patents:	87
US Patents:	13
Tradenames:	3
Ingredients:	3
NDAs:	3

Drugs and US Patents for Therapeuticsmd Inc

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Therapeuticsmd Inc	IMVEXXY	estradiol	INSERT;VAGINAL	208564-002	May 29, 2018		RX	Yes	Yes	9,289,382		Y
Therapeuticsmd Inc	BIJUVA	estradiol; progesterone	CAPSULE;ORAL	210132-001	Oct 28, 2018		RX	Yes	Yes	8,993,549		Y
Therapeuticsmd Inc	BIJUVA	estradiol; progesterone	CAPSULE;ORAL	210132-001	Oct 28, 2018		RX	Yes	Yes	9,301,920		Y
Therapeuticsmd Inc	IMVEXXY	estradiol	INSERT;VAGINAL	208564-001	May 29, 2018		RX	Yes	No
Therapeuticsmd Inc	BIJUVA	estradiol; progesterone	CAPSULE;ORAL	210132-001	Oct 28, 2018		RX	Yes	Yes	9,006,222		Y
Therapeuticsmd Inc	BIJUVA	estradiol; progesterone	CAPSULE;ORAL	210132-001	Oct 28, 2018		RX	Yes	Yes	8,846,648
Therapeuticsmd Inc	BIJUVA	estradiol; progesterone	CAPSULE;ORAL	210132-001	Oct 28, 2018		RX	Yes	Yes

International Patents for Therapeuticsmd Inc Drugs

Country	Document Number	Estimated Expiration
Japan	6397402
World Intellectual Property Organization (WIPO)	2013078422
European Patent Office	2861233
Japan	2015504924
South Africa	201500212
Japan	2015507607
Argentina	099872

Supplementary Protection Certificates for Therapeuticsmd Inc Drugs

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
09/012	Ireland		PRODUCT NAME: QLAIRA-ESTRADIOL VALERATE/DIENOGEST; NAT REGISTRATION NO/DATE: PA1410/58/1 20090109; FIRST REGISTRATION NO/DATE: BE327792 20081103
2016 00016	Denmark		PRODUCT NAME: LEVONORGESTREL OG ETHINYLOESTRADIOL; NAT. REG. NO/DATE: 56336 20151105; FIRST REG. NO/DATE: SK 17/0017/15-S 20150211
/2004	Austria		PRODUCT NAME: DROSPIRENON IN KOMBINATION MIT ESTRADIOL; NAT. REGISTRATION NO/DATE: 1-25178, 1-25179 20031127; FIRST REGISTRATION: NL RVG 27505 20021211
0136011/03	Switzerland		PRODUCT NMAE: ESTRADIOL UND MEDROXYPROGESTERONACETAT; REGISTRATION NO/DATE: IKS 55288 20000417
156	Luxembourg		PRODUCT NAME: LEVONORGESTREL ET ETHINYLESTRADIOL; FIRST REGISTRATION DATE: 20150211
C0002	Belgium		PRODUCT NAME: ESTRADIOL; NAT. REGISTRATION NO/DATE: NL 18978 19960731; FIRST REGISTRATION: SE - 11783 19930305
/2015	Austria		PRODUCT NAME: ETHINYLESTRADIOL UND EINE KOMBINATION VON LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 136021 20150224; FIRST REGISTRATION: SK 17/0017/15-S 20150211

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Theragen
• Therapeuticsmd Inc
• Theratechnologies
• Theravance Biopharma